PharmaOnco™ SARS-CoV2-Specific T cells (CAT#: ITS-0423-LX14)

Creative Biolabs offers SARS-CoV2-Specific T cells for immunity reaserch.

SARS-CoV2-specific T cells are a type of immune cell that specifically targets and recognizes the virus that causes COVID-19, known as SARS-CoV-2. These T cells play a crucial role in the body's immune response to the virus by identifying and attacking infected cells.

SARS-CoV2-Specific T cells are a type of immune cell that specifically recognize and target the SARS-CoV-2 virus, which is the virus responsible for COVID-19. These T cells play a crucial role in coordinating and directing the immune response against the virus, helping to eliminate infected cells and control the infection. Research has shown that a robust and specific T cell response is important for providing long-lasting immunity to SARS-CoV-2 and preventing reinfection.

Human

T cell population

We recommend RPMI-1640 with 10% FBS media for our functional analysis, but that depends on the media used by customers for co-culturing experiments.

High quality;
High viability;
Widely applications.

With proper stimulation, they will survive for about 4-5 days.

SARS-CoV2 Spike 424-433

HLA-A*0201